Citations

Mayo Clinic

Clear

720 citation(s) found for "Núñez, Gabriel".

Abstract 6475: Myeloma cells with therapy-induced senescence-like phenotype have increased resistance to killing by T cell directed therapies
Schaefers, Christoph, Guilatco, Angelo Jose, Arbelaez, Sofia, Wu, Chen , Corraes, Andre de Menezes Silva, Gupta, Malvika , Shao, Zuoyi, Regan, Kevin M., Kamal, Rayaan, Sannuli, Neal I., Li, Ying, Kourelis, T., Gonsalves, Wilson, Tan, Melinda, Abdallah, Nadine, Lin, Yi, Weivoda, Megan , Schaefers, Christoph , Borges, Gabriel Álvares , Corraes, Andre De Menezes Silva , Kourelis, Taxiarchis , Gonsalves, Wilson I. , Tan, Melinda, Abdallah, Nadine

Cancer Research | April 3, 2026 | Volume: 86 | Issue: 7_Supplement | Pages: 6475-6475

10.1158/1538-7445.am2026-6475 Get It

Abstract Background: Therapy-induced senescence (TIS), a tumor cell state associated with distinct gene expression patterns and implicated in therapy resistance, may be activated in Multiple Myeloma (MM) patients (pt) by genotoxic chemotherapies, such as high-dose melphalan (HDM). We investigated whether TIS is activated in MM cells following chemotherapy and linked to resistance to T-cell directed therapies. Method: We integrated scRNA-seq data from healthy donors (CNTRL) and MM pts (newly-diagnosed (NDMM), pre/post-CAR-T) bone marrow plasma cells (PCs) using two public datasets (Boiarsky, et al.; Dhodapkar, et al.) and a newly generated pt dataset. Senescence was evaluated using scGSEA with published gene sets (SenUp, SenGA, and SCAPs). For in vitro MM cytotoxicity assay, human H929 MM cells were treated with vehicle (Veh) or HDM (3µM, IC90) for 6h and examined for TIS features. H929VEH or H929HDM were co-cultured with CNTRL T cells with or without teclistamab (Tec, 10 nM) or with day 14 PBMCs from MM pts post-CAR-T (E:T 5:1). CAR+ T cells were high among the day 14 PBMC (median±SD: 93.4±7.2% of CD3+ cells, n=6). Results: scGSEA revealed significantly higher enrichment of SenUp, SenGA, and SCAPs in late-stage MM cells compared to NDMM and CNTRL (p<0.05). Expression of CDKN2A, encoding the senescence marker p16, was also increased in late-stage MM relative to NDMM/CNTRL PCs. Of interest, cells enriched for senescence also exhibited enrichment for myeloid markers (TET2, CEBP family). Notably, in pre-CAR-T, increased baseline senescence or myeloid marker expression showed an inverse association with CAR-T progression-free survival (PFS), suggesting TIS confers resistance to T cell mediated cytotoxicity. This may be due to myeloid plasticity. TIS MM cells generated in vitro, H929HDM, exhibited a distinct morphology characterized by increased cell size and enhanced cytoplasmic granularity. Increased CD14 expression was seen in 4 of the 6 experiments (median, range % increase: 11.2%, 2.5%-21%), consistent with myeloid plasticity; Increased KLRG1 expression was seen in 5 of the 7 experiments (median MFI ratio, range: 3.7, 1.3-471). No significant change was seen in GPNMB expression. Compared to H929VEH, H929HDM had a reduction in killing by CAR-T cells (median±SD: 22.8±32.94% n=6, p=0.016, Wilcoxon paired test). Similarly, H929HDM had a 10.69% decrease in Tec-mediated T-cell killing compared to H929VEH (n=8, p=0.02, Wilcoxon paired test). Conclusions: Late-stage MM cells exhibit transcriptional signatures consistent with TIS, which can be associated with decreased PFS to CAR-T. We report an in vitro model of TIS MM cells for testing of resistance to T cell killing. Based on these findings, a phase II trial (NCT06940297) is underway to test the hypothesis that peri-CAR-T senolytic therapy with dasatinib and quercetin will deepen responses by targeting this resistant TIS MM population. Citation Format: Christoph Schaefers, Angelo Jose Guilatco, Sofia Arbelaez, Gabriel Alvares Borges, Chen Wu, Andre de Menezes Silva Corraes, Malvika Gupta, Zuoyi Shao, Kevin Regan, Rayaan Kamal, Neal I. Sannuli, Ying Li, Taxiarchis Kourelis, Wilson Gonsalves, Melinda Tan, Nadine Abdallah, Yi Lin, Megan Weivoda. Myeloma cells with therapy-induced senescence-like phenotype have increased resistance to killing by T cell directed therapies [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 6475.
Non-Typhoidal Salmonella enterica Bacteremia Complicated by Native Shoulder Septic Arthritis in a Patient with Sickle Cell Disease Following Foodborne Exposure: A Case Report and Literature Review
Godart, Gabriel A. , Yadav, Vidit , Springer, Bryan D. , Durvasula, R, Elwasila, Sammer M., Oring, Justin , Godart, Gabriel , Bestic, Joseph M. , Oring, Justin , Schoch, Bradley S. , Elwasila, Sammer M

Infectious Disease Reports | April 2, 2026 | Volume: 18 | Issue: 2 | Pages: 30

10.3390/idr18020030 | PMID 42042319 Get It

Background/Objectives: Non-typhoidal Salmonella (NTS) species are well-recognized causes of invasive infection in patients with sickle cell disease (SCD), with a particular predilection for the musculoskeletal system. Although Salmonella osteomyelitis is well described in this population, septic arthritis is uncommon, especially involving the shoulder joint. We describe a case of NTS bacteremia complicated by native shoulder septic arthritis in a patient with SCD and review its clinical implications. Methods: We report the clinical course, diagnostic evaluation, microbiologic findings, imaging studies, and management of a 22-year-old man with homozygous SCD who presented with a vaso-occlusive pain crisis and subsequently developed severe sepsis with persistent Salmonella enterica bacteremia following ingestion of undercooked poultry. Persistent bacteremia prompted further evaluation for metastatic infection using advanced imaging and diagnostic arthrocentesis. Results: Whole-body imaging identified septic arthritis of the native right shoulder, which was confirmed by synovial fluid cultures growing Salmonella species. The patient underwent arthroscopic irrigation and debridement for source control. Antimicrobial therapy was narrowed to intravenous ceftriaxone based on susceptibility data and continued for six weeks. The patient demonstrated clinical improvement with resolution of bacteremia and was discharged to rehabilitation to complete therapy. Conclusions: This case highlights the importance of a careful exposure history, including foodborne sources, in patients with SCD presenting with invasive Salmonella infection. Persistent bacteremia should prompt early investigation for metastatic foci, and timely surgical source control combined with targeted antimicrobial therapy is essential for optimal outcomes in this population.
Key Insights From the International ICU Diary Conference 2025
Nydahl, Peter, Ewens, Bev, Debue, Anne‐Sophie , Fiorilla, Xavier, Gabriel, Kristin, Galazzi, Alessandro , Gallie, Louise , Groth, Nikolas, Hickey, Carly, Hudson, Mark, Lynch, Fiona , Maxwell, Nicola G , Mol, Margo van, Rose, Louise, Tantam, Kate , Karnatovskaia, Lioudmila V. , Jones, Christina, Nydahl, Peter , van Mol, Margo , Tantam, Kate , Nydahl, Peter , Ewens, Beverley , Debue, Anne-Sophie , Galazzi, Alessandro , Renner, Caroline I. E. , Rose, Louise , Jones, Christina

Nursing in Critical Care | March 31, 2026 | Volume: 31 | Issue: 3 | Pages: No page available

10.1111/nicc.70430 | PMID 41913061 Get It

ABSTRACT We report on the 2025 International ICU Diary Conference that provided a comprehensive update on current knowledge, innovations and global practices related to ICU diaries. Held in a 6‐week online format, the event featured 23 speakers and was attended by mean 69.7 (SD 20.5) participants per session. Topics included development of ICU diaries, use in special settings, digital diaries, survivors' and families' experiences, Post‐Intensive‐Care Syndrome and follow‐up and implementation projects. Highlights were innovative solutions for digital diaries and the report of persons with lived and living experiences with diaries, changing the focus on humanising critical care. Relevance for Practice ICU diaries support patient‐ and family‐centred care and should be implemented more widely across healthcare systems. Their successful adoption requires contextual adaptation and policy support, with future development likely to be shaped by the increasing use of digital ICU diaries.
Interplay of pulmonary circulation, cardiac filling pressures, and sympathovagal balance in exercise-induced hyperventilation among cardiopulmonary disorders
Vicenzi, Marco , Rodrigues, Gabriel Dias , Deboeck, Gaël , Colombo, Marinella, Rota, Irene, Mozzo, Marta , Tersalvi, Gregorio , Carugo, Stefano, Montano, Nicola, Vachiéry, Jean-Luc, Borne, Philippe van de, Vicenzi, Marco , Dias Rodrigues, Gabriel , Caravita, Sergio , Deboeck, Gael , Tersalvi, Gregorio , Tobaldini, Eleonora , Montano, Nicola , Vachiéry, Jean‐Luc , van de Borne, Philippe , Carugo, Stefano , Montano, Nicola , Borne, Philippe van de

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology | March 23, 2026 | Volume: 330 | Issue: 5 | Pages: R480-R488

10.1152/ajpregu.00094.2025 | PMID 41870396 Get It

The results underscore a multifaceted interaction among cardiopulmonary hemodynamics, right heart pressures, ventilatory response, and autonomic regulation. In particular, altered RV-PA coupling correlated with heightened sympathetic drive, indicating that cardiopulmonary efficiency and hemodynamics may influence central autonomic outputs. This suggests that mechanical stress or overload in the right heart could modulate sympathovagal balance, thereby contributing to altered autonomic responses during exercise in patients with cardiopulmonary disorders.
International Dermoscopy Society consensus recommendations for the management of lentigo maligna
Forsea, Ana‐Maria , Akay, Bengü Nisa , Argenziano, Giuseppe, Briatico, Giulia , Cabo, Horacio , Cabrera, Raul, Carrera, C., Cinotti, Elisa, Conforti, Claudio, Errichetti, Enzo , Ferrara, Gerardo, Guida, Stefania, Guitera, Pascale, Heyes, Stephen J., Hofmann‐Wellenhof, R, Hong, A., Jaimes, Natalia , Karls, Raimonds, Kittler, Harald, Kränke, Teresa, Malvehy, Josep, Marghoob, Ashfaq A., Moneib, Hoda, Ramirez, David Moreno, Navarrete‐Dechent, Cristian, Pellacani, Giovanni, Peris, Ketty, Puig, S, Rudnicka, Lidia, Sadek, Ahmed, Saiag, Philippe, Soyer, Hans Peter, Starace, Michela V., Stolz, Wilhelm, Swanson, David C. , Thomas, Luc, Zalaudek, Iris, Lallas, Aimilios, Akay, Bengu Nisa , Apalla, Zoe , Argenziano, Giuseppe , Briatico, Giulia , Carrera, Cristina , Conforti, Claudio , Halpern, Allan C , Kränke, Teresa , Liopyris, Konstantinos , Liu, Jie , Moscarella, Elvira , Nagore, Eduardo , Navarrete-Dechent, Cristian , Paoli, John , Pellacani, Giovanni , Peris, Ketty , Puig, Susana , Rudnicka, Lidia , Scope, Alon , Starace, Michela V , Swanson, David L, Thomas, Luc , Tschandl, Philipp , Lallas, Aimilios , Pampena, Riccardo , Braun, Ralph Peter , Cabrera, Raúl , Cinotti, Élisa , Ferrara, Gerardo , Giuffrida, Roberta , Guida, Stefania , Guitera, Pascale , Heyes, Stephen, Karls, Raimonds, Kittler, Harald , Kränke, Teresa, Longo, Caterina , Malvehy, Josep , Marghoob, Ashfaq A. , Navarrete‐Dechent, Cristián , Peris, Ketty , Puig, Susana , Rosendahl, Cliff O. , Saïag, Philippe , Salerni, Gabriel , Scope, Alon , Soyer, H. Peter , Stolz, Wilhelm , Zalaudek, Iris

Journal of the European Academy of Dermatology and Venereology | March 19, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/jdv.70406 | PMID 41854120 Get It

Abstract Lentigo maligna (LM) is a subtype of cutaneous melanoma in situ that develops on chronically sun‐damaged skin in elderly individuals. Its diagnosis and management remain challenging due to its slow progression, frequent occurrence on cosmetically sensitive areas in frail individuals, and tendency for subclinical peripheral extension. Despite its potential for invasive transformation, the natural history of LM remains incompletely understood and evidence‐based management strategies for this specific entity remain limited. This work aims to bridge the gap between scarce high‐quality evidence and the clinicians' need for practical guidance on LM management by formulating evidence‐based and expert consensus‐driven recommendations for diagnosis, treatment and follow‐up. Under the coordination of the International Dermoscopy Society, a global, multidisciplinary consortium of 53 experts—including dermatologists, dermato‐oncologists, dermatologic surgeons, radiologists, radiotherapists, pathologists and epidemiologists—formulated recommendations through structured consensus, informed by a comprehensive review of current scientific evidence and clinical practice standards. Optimal management of LM requires accurate diagnosis and individualized treatment planning. Non‐invasive skin imaging techniques, especially dermoscopy and reflectance confocal microscopy, aid in diagnosis, biopsy orientation, lesion delineation and post‐treatment monitoring. Multiple partial biopsies help confirm diagnosis and rule out invasion. Complete surgical excision remains the first treatment option. No definitive safety margins can be recommended for standard surgery; margin‐controlled techniques are preferable for large or ill‐defined lesions. Topical imiquimod and radiotherapy are effective alternatives where surgery is unsuitable. Topical imiquimod is useful as primary, adjuvant or neoadjuvant therapy. Blind destructive methods should be avoided. Close clinical and imaging follow‐up is needed. Patient‐centred care, shared decision‐making, and a multidisciplinary approach are critical for optimal outcomes. These international consensus recommendations summarize current best practices for LM management, offering practical, evidence‐informed guidance to clinicians while acknowledging the potential of future research in refining these conclusions.
Long-term follow-up of S0221, comparing alternative dose-schedules of anthracycline and taxane therapy in early breast cancer
Barlow, William E. , Moore, Halle C F, Hobday, T., Isaacs, Claudine, Salim, Muhammad , Albain, Kathy S. , Chew, Helen K. , Burton, G., Srkalović, Gordan , Flaherty, Lawrence E. , Lew, Danika L., Hortobagyi, Gabriel N, Sharma, Priyanka, Pusztai, Lajos, Budd, George T, Moore, Halle C. F. , Isaacs, Claudine , Ali, Azka , Barlow, William E , Moore, Halle C F , Isaacs, Claudine , Albain, Kathy , Srkalovic, Gordan , McGregor, Bradley , Gralow, Julie R , Sharma, Priyanka , Pusztai, Lajos , Budd, G Thomas , Hobday, Timothy J. , McGregor, Bradley A. , Gralow, Julie R. , Hortobágyi, Gabriel N. , Sharma, Priyanka , Pusztai, Lajos , Budd, G. Thomas

JNCI Cancer Spectrum | March 12, 2026 | Volume: 10 | Issue: 2 | Pages: No page available

10.1093/jncics/pkag024 | PMID 41832961 Get It

Abstract Background S0221 investigated weekly vs every 2 weeks dosing of doxorubicin (A) and cyclophosphamide (C) followed by paclitaxel in patients with high-risk early breast cancer. After an interim analysis, random assignment to the 2 AC arms was stopped for futility, and the trial was modified to study only the paclitaxel schedules. Methods Between December 2003 and November 2010, a total of 2716 patients were randomly assigned in a 2 × 2 factorial design to 15 weeks of weekly A and daily C vs 6 cycles of every 2 weeks AC; and weekly paclitaxel for 12 weeks vs 6 cycles of every 2 weeks paclitaxel. Between January 2011 and January 2012, an additional 578 patients were assigned to 4 cycles of every 2 weeks AC and randomly assigned to weekly vs every 2 weeks paclitaxel. Updated survival was assessed using log-rank tests and Cox regression models. We compared outcomes by breast cancer subtype as well. Results At a median follow-up of 12.1 years, there were no statistically significant differences among the 4 treatment arms in disease-free survival (DFS) (P = .91) or overall survival (P = .34) in the original protocol. Among the 578 patients assigned AC for 4 cycles and randomly assigned to paclitaxel weekly vs every 2 weeks paclitaxel, there were no overall differences in DFS (P = .32) or overall survival (P = .42). Conclusion As there were no statistically significant outcome differences in DFS or overall survival between the studied schedules of AC and paclitaxel with extended follow-up in the original or revised protocol, either paclitaxel schedule may be recommended, with selection based on toxicity, cost, or patient preference.
Adolescent Normative Intervals for Body Surface Gastric Mapping: Spectral Analysis
Humphrey, Gayl , Schamberg, Gabriel , Xu, Binghong , Dachs, Nicky , Foong, Daphne , Varghese, Chris, Andrews, C N, O'Grady, Gregory, Schamberg, Gabriel , Varghese, Chris , Mousa, Hayat M. , Gharibans, Armen A.

Neurogastroenterology & Motility | March 12, 2026 | Volume: 38 | Issue: 3 | Pages: No page available

10.1111/nmo.70282 | PMID 41814464 Get It

ABSTRACT Background Body surface gastric mapping (BSGM) non‐invasively assesses gastric myoelectrical activity along with real‐time symptom reporting. In adults, the development of normative intervals has underpinned new explanatory phenotypes, aiding clinical decision‐making. This study established normative reference intervals for adolescent BSGM metrics. Methods Healthy adolescents aged 12–17 years with a BMI ≤ 35 kg/m 2 were recruited from New Zealand, Australia, and the United States. BSGM using Gastric Alimetry (Alimetry, New Zealand) involved a 30‐min fast, followed by a 480‐kcal meal, and a 4‐h postprandial recording. Reference intervals were calculated for four validated metrics: Principal Gastric Frequency (PGF), body mass index (BMI)‐adjusted amplitude, Gastric Alimetry Rhythm Index (GA‐RI, indicating rhythm stability), and the fed: fasted amplitude ratio (ff‐AR). Results were reported at the median and 5th and/or 95th percentiles as appropriate. Key Results A total of 107 participants (52.8% female, median age 14 [IQR 13–16], median BMI 20.1 [IQR 18.75–22.40]) with mixed ethnicities were included. No substantive correlations were observed between BSGM metrics and demographics or anthropometric data. Therefore, a single set of normative reference intervals was established. Median PGF was 3.06 cycles per minute; reference interval 2.72–3.37. Median BMI‐adjusted amplitude was 37.80 μV; reference interval 20.0–72.0. Median GA‐RI was 0.51; reference interval ≥ 0.22. Median ff‐AR was 2.12; reference interval ≥ 1.0. Conclusions and Inferences This study presents normative reference intervals for BSGM spectral metrics in adolescent populations, informing the interpretation of tests in research and clinical practice.
Feasibility in the detection of sentinel lymph node-associated blood vessels using intravital microscopy in patients undergoing sentinel lymph node biopsy for melanoma
Gabriel, Emmanuel, Fisher, Daniel T., Kim, Minhyung , Ma, Xiaoyi , Francescutti, Valerie , Kane, John M., Evans, Sharon S. , Skitzki, Joseph J. , Attwood, Kristopher M. , Kane, John M.

Frontiers in Imaging | March 9, 2026 | Volume: 5 | Issue: No issue available | Pages: No page available

10.3389/fimag.2026.1758694 Get It

While the clinical focus on the sentinel lymph node biopsy (SLNB) is the presence of intra- or extra-nodal metastases, preclinical studies suggest that tumor-draining SLNB-associated vascular architecture and adhesion properties are altered regardless of SLNB positivity. Human intravital microscopy (HIVM) has defined blood vessel abnormalities that may impact lymphocyte adhesion and systemic drug delivery at primary melanoma sites. In this pilot study of HIVM during melanoma SLNB, we sought to determine the feasibility of obtaining HIVM observations of SLNB-associated vessels. We successfully performed HIVM in all 20 SLNB patients, and 7 were found to have nodal micrometastases by standard pathology. HIVM was capable of identifying both functional and non-functional SLNB-associated vessels based on the presence or absence of fluorescent dye uptake, respectively. Comparing vessel characteristics as a secondary exploratory objective, no statistically significant differences were noted in the diameter, flow rate, functionality, or shear stress of SLNB-associated blood vessels between positive and negative SLNBs, which may likely have been a reflection of the minimal disease burden. Nonetheless, these initial observations provide the framework to optimize future trials of HIVM in cancer patients.
Expanding the Motor Band Sign in Motor Neuron Disease Using 7T MRI : Visualization of Cortical Layer‐Dependent Iron Deposition in the Primary Motor Cortex
Shah, Jaimin, Sledge, Hanna J, Virador, Gabriel M. , Middlebrooks, Erik H. , Shah, Jaimin , Zhou, Xiangzhi , Virador, Gabriel, Parizadeh, Donna , Middlebrooks, Erik H , Oskarsson, Björn , Heckman, Michael G. , Sledge, Hanna J., Parizadeh, Donna, Parizadeh, Donna

Muscle & Nerve | March 8, 2026 | Volume: 73 | Issue: 6 | Pages: 996-1004

10.1002/mus.70179 | PMID 41792976 Get It

ABSTRACT Introduction/Aims There are no established biomarkers of upper motor neuron degeneration to aid in the diagnosis of motor neuron disease (MND). This study examines the diagnostic value of the motor band sign as a marker of upper motor neuron degeneration and its relationship to clinical findings in MND. Methods Records of consecutive patients who underwent 7T magnetic resonance imaging (MRI) between October 2021 and April 2025 for evaluation of MND or other neurologic indications were retrospectively reviewed. Clinical variables and plasma neurofilament light chain (pNfL) levels were recorded. An upper motor neuron score (Mayo UMNS) was derived from reflex scores. Blinded MRI review assessed the degree of susceptibility‐weighted imaging (SWI) hypointensity in the hand, foot, and bulbar motor cortex regions. Results An MBS was observed in 100 of 117 (85.5%) MND patients and in 16 (15.5%) patients with non‐MND diagnoses, corresponding to a sensitivity of 85.5% (78.0%–90.7%) and 84.5% (76.2%–90.2%) specificity. The MBS in 78 MND patients (70.9%) preferentially involved the middle and deep cortical layers, giving a trilaminar appearance, while only one non‐MND patient had this finding. Mayo UMNS ( β = 0.89, p < 0.001), pNfL ( β = 0.63, p = 0.033), and age at evaluation ( β = 0.68, p = 0.027) were independently associated with the summed SWI score. Discussion The 7T MRI MBS is a sensitive and specific marker for MND that complements established clinical evaluation. Using 7T, a trilaminar appearance of the motor cortex, reflecting known histopathological changes, can be visualized and may be specific to MND.
Brain Sphingolipid and Phospholipid Levels Are Altered in XK Disease
Miltenberger-Miltenyi, Gabriel, Laborc, Klaudia, Jones, Attila, Crary, John F. , Sanctis, Claudia De , Thörn, Emma, Chiu, Lily Yu-Chia, McQuillan, Stephanie, Farrell, Kurt , Nandakumar, Renu , Al-Sarraj, S, Dickson, Dennis, Hiller, Amie , MORGELLO, SUSAN, Sammler, Esther , Troakes, Claire, Hecke, Wim Van, Westeneng, Henk-Jan, Woltjer, Randall, Wszolek, Zbigniew K, Walker, Ruth, Jones, Attila , McQuillan, Stephanie , Farrell, Kurt , Al-Sarraj, Safa , Sammler, Esther M , Woltjer, Randall L. , Miltenberger-Miltényi, Gábriel , Conceição, Vasco A. , Thorn, Emma L , Morgello, Susan , Mühlebner, Angelika , Troakes, Claire , Hecke, Wim Van , Westeneng, Henk‐Jan , Wszołek, Zbigniew K.

Movement Disorders | March 8, 2026 | Volume: 41 | Issue: 7 | Pages: 1877-1883

10.1002/mds.70220 | PMID 41730688 Get It

Abstract Background XK disease is a multisystem neurodegenerative disorder caused by mutations in the XK gene that codes for the lipid scramblase XK. Objective The aim was to describe the lipidomic spectrum in postmortem brain tissue from XK patients. Methods We measured the levels of 593 lipid species in the caudate nucleus (CN), putamen, and dorsolateral prefrontal cortex (DLPFC) from postmortem tissues of 5 XK patients and 6 controls. Results In XK patients, we observed increased levels of triacylglycerol, monoacylglycerol, phosphatidylserine, and ceramide in the CN. Acylated phosphatidylglycerol levels were reduced in both the CN and putamen. Acyl carnitine, dihydrosphingomyelin, and monosialodihexosylganglioside were reduced, whereas N ‐acyl phosphatidylethanolamine was increased in the DLPFC. N ‐Acyl serine was reduced in all three regions. Conclusions Our findings provide initial evidence of abnormal sphingolipid and phospholipid concentrations in the brains of XK patients and may provide insights into mechanisms of neurodegeneration in this disease. © 2026 International Parkinson and Movement Disorder Society.